Incanthera (AQSE:INC) Operating Cash Flow per Share : £-0.00 (TTM As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Incanthera Operating Cash Flow per Share?

Incanthera's operating cash flow per share for the six months ended in Sep. 2023 was £-0.00. Incanthera's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 15.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Incanthera's Operating Cash Flow per Share or its related term are showing as below:

AQSE:INC' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 15.7 Med: 15.7 Max: 15.7
Current: 15.7

During the past 4 years, Incanthera's highest 3-Year average Operating Cash Flow per Share Growth Rate was 15.70% per year. The lowest was 15.70% per year. And the median was 15.70% per year.

AQSE:INC's 3-Year OCF Growth Rate is ranked better than
62.19% of 1235 companies
in the Biotechnology industry
Industry Median: 3.4 vs AQSE:INC: 15.70

Incanthera Operating Cash Flow per Share Historical Data

The historical data trend for Incanthera's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Operating Cash Flow per Share Chart

Incanthera Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Operating Cash Flow per Share

-0.01

Incanthera Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Operating Cash Flow per Share	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Incanthera's Operating Cash Flow per Share

For the Biotechnology subindustry, Incanthera's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Incanthera's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Incanthera's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Incanthera's Price-to-Operating-Cash-Flow falls into.

Incanthera Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Incanthera's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (A: Mar. 2023 )	=	Cash Flow from Operations (A: Mar. 2023 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2023 )
	=	-0.453	/	75.212
	=	-0.01

Incanthera's Operating Cash Flow per Share for the quarter that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (Q: Sep. 2023 )	=	Cash Flow from Operations (Q: Sep. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2023 )
	=	-0.105	/	77.242
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.00

Incanthera Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Incanthera's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Incanthera (AQSE:INC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

76 King Street, Manchester, GBR, M2 4NH

Website

http://www.incanthera.com

Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines